Loading
Travere Therapeutics
  • Home
  • National Kidney Month
  • Transition
  • Revised Pipeline Animated Graphic
  • Editable Therapeutic Areas
  • Senior Leadership
    • Chris Cline
    • Peter Heerma
    • Eric Dube, Ph.D.
    • Laura M. Clague, CPA
    • Noah L. Rosenberg, M.D.
    • Jula Inrig, M.D.
    • Laura M. Johnson
    • Casey Logan
    • William Rote, Ph.D.
    • Elizabeth Reed, J.D.
  • Medical Education Grants
  • About Us
    • COVID-19
  • Our Culture
    • Equity, Diversity & Inclusion
    • Our Why
  • Privacy
    • Individual Rights Request Form
      • Thank you
    • California Privacy Policy
    • Clinical Trials Privacy Policy
    • Website Cookies Policy
    • Corporate Privacy Policy
  • Patient Advocacy
  • Diagnostic Testing Programs
  • INVESTIGATOR-SPONSORED RESEARCH
  • Contact Us
  • Thank You for Contacting Us
  • Our Pipeline
    • TVT-058
    • ALGS COLLABORATION
    • Sparsentan for IgAN
    • Sparsentan for FSGS
    • Chenodeoxycholic Acid (CDCA) Program
    • NGLY1 Collaboration
    • Clinical Trials
  • Our Therapies
  • Board of Directors
    • Suzanne L. Bruhn, Ph.D.
    • Sandra E. Poole
    • Gary A. Lyons
    • Stephen Aselage
    • Ruth Williams-Brinkley
    • Roy D. Baynes, M.D., Ph.D.
    • Tim Coughlin, CPA
    • Jeffrey A. Meckler
    • John A. Orwin
    • Ron Squarer
  • Careers
  • Pathfinder
  • Expanded Access
  • Terms & Conditions
  • Community Guidelines
  • Patients & Caregivers
  • Therapeutic Areas
    • Classical Homocystinuria (HCU)
    • ALAGILLE SYNDROME (ALGS)
    • IgA NEPHROPATHY (IgAN)
    • N-GLYCANASE 1 (NGLY1) DEFICIENCY
    • FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    • CYSTINURIA
    • CEREBROTENDINOUS XANTHOMATOSIS (CTX)
    • PEROXISOME BIOGENESIS DISORDER-ZELLWEGER SPECTRUM DISORDER (PBD-ZSD)
    • BILE ACID SYNTHESIS DISORDERS (BASD)
  • Search
  • Menu Menu
You are here: Home1 / Transition

Retrophin is now Travere Therapeutics.

Read More

×

© 2022 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.

Terms and Conditions | Privacy Policies | Cookie Settings

Follow a manual added link

Scroll to top